Target
Somatostatin receptor type 2
Ligand
BDBM50075277
Substrate
n/a
Meas. Tech.
ChEBML_200682
Ki
11±n/a nM
Citation
 Pasternak, APan, YMarino, DSanderson, PEMosley, RRohrer, SPBirzin, ETHuskey, SEJacks, TSchleim, KDCheng, KSchaeffer, JMPatchett, AAYang, L Potent, orally bioavailable somatostatin agonists: good absorption achieved by urea backbone cyclization. Bioorg Med Chem Lett 9:491-6 (1999) [PubMed]
Target
Name:
Somatostatin receptor type 2
Synonyms:
SOMATOSTATIN SST2 | SRIF-1 | SS-2-R | SS2-R | SS2R | SSR2_HUMAN | SSTR2 | Somatostatin receptor type 2 (SSTR2)
Type:
Enzyme
Mol. Mass.:
41344.94
Organism:
Homo sapiens (Human)
Description:
P30874
Residue:
369
Sequence:
MDMADEPLNGSHTWLSIPFDLNGSVVSTNTSNQTEPYYDLTSNAVLTFIYFVVCIIGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMITMAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYTFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSMAISPTPALKGMFDFVVVLTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGTDDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
  
Inhibitor
Name:
BDBM50075277
Synonyms:
(2R,3S)-N-(5-Amino-[1,3]dioxan-2-ylmethyl)-3-(1H-indol-3-yl)-N-methyl-2-[2-oxo-3-(3-phenyl-propyl)-imidazolidin-1-yl]-butyramide | CHEMBL356717
Type:
Small organic molecule
Emp. Form.:
C30H39N5O4
Mol. Mass.:
533.6618
SMILES:
C[C@H]([C@@H](N1CCN(CCCc2ccccc2)C1=O)C(=O)N(C)C[C@H]1OC[C@H](N)CO1)c1c[nH]c2ccccc12 |wU:2.2,23.24,wD:26.28,1.0,(-1.32,3.36,;-1.3,1.82,;.03,1.05,;1.36,1.84,;1.36,3.38,;4.03,3.39,;4.03,1.85,;5.39,1.09,;6.71,1.87,;8.05,1.11,;9.38,1.89,;9.36,3.43,;10.69,4.2,;12.03,3.45,;12.05,1.91,;10.72,1.12,;2.7,1.07,;2.72,-.48,;.03,-.48,;1.59,-.49,;-.74,-1.81,;-2.28,-1.8,;.01,-3.16,;-.76,-4.47,;.01,-5.83,;-.79,-7.16,;-2.33,-7.14,;-3.13,-8.47,;-3.08,-5.8,;-2.31,-4.47,;-2.63,1.04,;-2.63,-.5,;-3.97,-1.29,;-5.3,-.51,;-6.63,-1.29,;-7.97,-.51,;-7.97,1.03,;-6.63,1.82,;-5.3,1.04,)|
Structure:
Search PDB for entries with ligand similarity: